Ed Snape

Designs, manufactures and markets medical devices

Manufactures door panels and composite doors

Supplies molecular spectroscopy systems and applications for chromatography

Engages in the acquisition, exploration and development of base & precious metal projects

Develops novel technologies for treatment of peripheral nerves

Operates as a special purpose acquisition company

Provides clinical modalities used in minimal and micro-invasive medical procedures

Functions as a College/University

Manufactures food and beverage packaging products

NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting. The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO. NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors. They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization.

Develops molecular diagnostic fungal testing kits

Nexus Medical seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of medical technology and life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. They prefer to lead their investments and to work in a hands-on manner with the portfolio companies, committing multiple partners to each investment. It provides financing for seed and early stage capital requirements.

Operates as a healthcare diagnostics company

Manufactures and markets electrical products

Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases

Operates a portfolio of company shareholdings in both the healthcare and environmental sectors

Vista Private Equity Group invests in companies located in the United States primarily in Texas and Southern US with an EBITDA of USD 1-10 million and revenue of USD 10-50 million. The firm focuses on business services, manufacturing/industrial, distribution/logistics, infrastructure services, environmental, energy sectors. It provides financing for growth, corporate carve-outs, distress/turnaround and buyout transactions with an investment size of USD 5-50 million and also acquires majority controlling positions.

Develops light-based disinfectant devices and procedures